Vishnu Patel, MD
Pulmonary Disease · Princeton, WVNPI 1265400865
Payments from drug & device makers
Across 523 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Boehringer Ingelheim$1K
- Jazz Pharmaceuticals Inc.$475
- Takeda Pharmaceuticals U.S.A., Inc.$464
- Axsome Therapeutics, Inc.$360
- plus $3K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 139 | $2,951 |
| GSK | 123 | $1,808 |
| Boehringer Ingelheim | 58 | $1,039 |
| Jazz Pharmaceuticals Inc. | 18 | $475 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $464 |
| Axsome Therapeutics, Inc. | 18 | $360 |
| Baxter Healthcare | 14 | $325 |
| Pulmonx Corporation | 15 | $322 |
| Mylan Specialty L.p. | 16 | $299 |
| Amgen | 12 | $242 |
| Regeneron Healthcare Solutions, Inc. | 12 | $207 |
| AbbVie(2 entities) | 7 | $165 |
| Inspire Medical Systems, Inc. | 2 | $163 |
| United Therapeutics Corporation | 1 | $157 |
| Sanofi | 7 | $156 |
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| Philips North America LLC | 6 | $111 |
| Verona Pharma, Inc. | 5 | $108 |
| Harmony Biosciences LLC | 5 | $101 |
| Sunovion Pharmaceuticals Inc. | 5 | $94 |
| Grifols USA, LLC | 3 | $72 |
| Viatris Specialty LLC | 3 | $64 |
| Insmed, Inc. | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 1 | $59 |
| CSL Behring | 2 | $52 |
| Shire North American Group Inc | 3 | $50 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Merck | 2 | $33 |
| Apria Healthcare LLC | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Inogen, Inc. | 2 | $15 |
| Electromed, Inc. | 1 | $14 |
How this compares
$10,215 in reported general payments places this provider in the 85th percentile of 89 pulmonary disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Princeton
- Maria BoustaniBeckley$663K
- Loay Al AsadiCharleston$461K
- Melvin SaludesGlen Dale$255K
- Amro Al-AstalHuntington$231K
- Roger AbrahamsMorgantown$177K
- Ramzi HaddadinBeckley$43K
- Houssein YounessMartinsburg$31K
- Salam RajjoubBridgeport$29K
- Ronald MudryElkins$23K
- Peter KochupuraMorgantown$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.